The Basic Documentation for Psycho-Oncology in Pediatric Stem Cell Transplantation Recipients: Ratings of Parents and Staff and the Profile of Salivary α-Amylase

Table 1

Patient characteristics.

	Total		Allogeneic HSCT		Autologous HSCT
	n	(%)	n	(%)	n	(%)
Total	39	(100.0)	31	(100.0)	8	(100.0)
Age
Median (range)	9.3 (0.5–19)		6.0 (2.8–19)		9.5 (0.5–18.3)
Sex
Male	21	(53.8)	15	(48.4)	6	(75.0)	0.2472
Female	18	(46.2)	16	(51.6)	2	(25.0)
Diagnosis
Malignant	26	(66.7)	18	(58.1)	8	(100.0)	0.0352
Non-malignant	13	(33.3)	13	(41.9)	0	(0.0)	0.0352
Acute lymphoblastic leukemia	6	(15.4)	6	(19.4)	0	(0.0)	0.3133
Acute myeloid leukemia	5	(12.8)	5	(16.1)	0	(0.0)	0.5628
Ewing’s sarcoma	2	(5.1)	1	(3.2)	1	(12.5)	0.3725
Myelodysplastic syndromes	2	(5.1)	2	(6.5)	0	(0.0)	>0.9999
Neuroblastoma	6	(15.4)	5	(16.1)	1	(12.5)	>0.9999
Sickle cell anemia	5	(12.8)	5	(16.1)	0	(0.0)	0.5628
Others	13	(33.3)	7	(22.6)	6	(75.0)	0.0098
HSCT donor
Autologous	8	(20.5)	0	(0.0)	8	(100.0)	<0.001
Matched unrelated donor	8	(20.5)	8	(25.8)	0	(0.0)	0.1683
Matched sibling donor	10	(25.6)	10	(32.3)	0	(0.0)	0.0862
Mismatched family donor	13	(33.3)	13	(41.9)	0	(0.0)	0.0352
Graft-versus-host disease
Grade I	10	(25.6)	10	(32.3)	n.a.
Grade II	5	(12.8)	5	(16.1)	n.a.
Grade III	0	(0.0)	0	(0.0)	n.a.
Grade IV	0	(0.0)	0	(0.0)	n.a.
Daycare/school/work
Daycare/kindergarten	10	(25.6)	8	(25.8)	2	(25.0)	>0.9999
School	23	(59.0)	19	(61.3)	4	(50.0)	0.6937
Others	6	(15.4)	4	(12.9)	2	(25.0)	>0.9999
Parents
Married	32	(82.1)	26	(83.9)	6	(75.0)	0.6170
Divorced/separated	6	(15.4)	5	(16.1)	1	(12.5)	>0.9999
Widow(er)	1	(2.6)	0	(0.0)	1	(12.5)	0.2051
Death	6	(15.4)	6	(19.4)	0	(0.0)	0.3133

HSCT-hematopoietic stem cell transplantation; n-sample size-probability value.